MUKKA — Mukka Proteins Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeSmall CapNeutral

Annual income statement for Mukka Proteins, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	5,492	6,038	7,705	11,771	13,798
Cost of Revenue
Gross Profit	678	830	1,298	2,198	2,231
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	5,290	5,858	7,285	10,946	12,858
Operating Profit	202	181	420	825	940
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	197	155	360	659	875
Provision for Income Taxes
Net Income After Taxes	136	110	258	475	743
Minority Interest
Net Income Before Extraordinary Items
Net Income	132	89.8	242	441	701
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	132	89.8	242	441	701
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.439	0.201	0.78	1.44	2.32
Dividends per Share